238TiP An update on the CONCORDE study: A phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC
A. Horne, Gerard Walls, Steven Brown, A. Chalmers et autres
gb (code pays fourni par la source)